Navigation Links
BioMS Medical Announces Second Quarter 2008 Results
Date:8/12/2008

tanding, 26,021,528 warrants and 9,161,500 stock options.

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298 (dirucotide), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 (dirucotide) in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Corporation's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demons
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... Managing the transition from perimenopause to po...ewswire/ -- The increasing frequency and intensity...periencing menopause. OBG Management and The Jo...a supplement titled Vasomotor symptoms: Managing ... . In this supplement, James McGregor, MD, CM and ...
(Date:12/2/2008)... PHILADELPHIA, Dec. 2 e..., a leading provider of centralized ECG and eClini...armaceutical, biotechnology,medical device and r...l J.,McKelvey, the Company,s President and Chief ...,s Chief Financial Officer, are scheduled to prese...
(Date:12/2/2008)... TAMPA, Fla., Dec. 2 Associated C...ology group practice that operates seven locations...has selected Sage Intergy EHR,electronic health r...on. The,Cherry Hill, N.J.-based practice, which c... deploy the single-database, integrated solution t...
(Date:12/2/2008)... CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCal...roNext: TPI), a manufacturer and supplier,of mode...in Chengdu, China,today announced the implementa...egorize both distributors and hospital clients int...and marketing structure. , The new strategy...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3
...Roche Discovery Welwyn, 40 Broadwater Road, Welwyn...nt Address: Analytical Sciences, , Syngen...racknell, Berkshire, , RG42 6EY, UK, ...e use of the Bio-Rad PROTEAN Plus Dodeca cell (Fig...ls with preparative protein loads. The Dodeca , ...
... and Carolyn Seggerson 2 , 1 Tech/Aid, , ... 2 Bio-Rad Laboratories, , Inc., 2000 Alf... , Introduction , Running PCR...uming procedure. , It is common to hand c..., A gel of such large size is difficult to...
, , , , back to top
...ction , Amplification of DNA through the...ighly sensitive method capable of copying millions...lecule. 1 Because of the extreme sensitivity of t... previous reactions can result in false positives ...n can be avoided by using positive , disp...
Other Biology Technology:Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 2Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 3Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 4Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 5Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 2Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 3Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 4Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3
(Date:12/2/2008)...views of nutrition related topics raises unique ch...icine. In a new article, a team of researchers use...s, and limitations of systematic reviews relevant ...he results. , Systematic reviews, also referred...ssessments with pre-specified questions that can b...
(Date:12/1/2008)...- The International Atomic Energy Agency (IAEA) to...eding technique that could bolster efforts aimed a...p. , IAEA scientists use radiation to produce im...imate conditions such as drought or flood, or that...s. Called mutation induction, the technique is saf...
(Date:12/1/2008)...sts around the world may benefit from a powerful n...help them to home in on the parts of proteins most...D, associate professor of pathology and of genetic...ecently launched the novel bioinformatics tool, wh...the role different proteins play in a wide array o...
(Date:12/1/2008)...niversity of Florida, keeper of the world,s shark ...records collection for another toothy marine preda...rum or "saw" that makes it a popular curio item an...orical and cultural icon that is rapidly disappear...urator of both the International Shark Attack File...
Breaking Biology News(10 mins):Experts discuss applying systematic review to the field of nutrition 2Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 1AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 3AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 4Springer launches new journal in musculoskeletal medicine 7194 1Springer launches new journal in musculoskeletal medicine 7194 2FDA Mulls Cutting Salt in Processed Foods 7192 1FDA Mulls Cutting Salt in Processed Foods 7192 2FDA Mulls Cutting Salt in Processed Foods 7192 3FDA Mulls Cutting Salt in Processed Foods 7192 4Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 1Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 2Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 3Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 4
...sity after the end-Cretaceous mass extinction was ...ng to paleontologists. New fossil evidence shows t...diversity were severely out of balance, not linked... million years ago. Labeled the K-T extinction, it...aleocene Epoch. , "The K-T caused major extinctio...
...volving five major food crops grown under carbon-d...ing dramatically less bounty than those raised in ...ons ?and scientists warn that global food supplies...rategies. , The new findings are based on on-going...t Urbana-Champaign and results gleaned from five o...
...archers have developed a way to synthesize a cance...ity to learn how it works. , Derived from a fungus... cave, the chemical tricks certain cancer cells in..., "In 2000, scientists in Japan discovered that t...as a prototype anticancer agent, but no one has be...
...delivered by a robotic arm eradicated lung tumors ...ment, medical physicist Cihat Ozhasoglu, Ph.D. of ...eport in early August at the 48th Annual Meeting o...ne in Orlando. Although it is too early to determ...oglu and his colleagues find promise in this new a...
Other Biology News:Insect predation sheds light on food web recovery after the dinosaur extinction 2Insect predation sheds light on food web recovery after the dinosaur extinction 3Insect predation sheds light on food web recovery after the dinosaur extinction 4Food-crop yields in future greenhouse-gas conditions lower than expected 2New lab technique churns out fungus' potential cancer fighter 2Radiation-armed robot rapidly destroys human lung tumors 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: